Otsuka acquires Transcend for $700M, including $525M in potential milestones, gaining PTSD drug candidate. #biopharma #psychiatry #M&A
biopharmadive.com/news/otsuka-tr…
Otsuka picks up PTSD drug with $700M Transcend buy
The buyout, which includes another $525 million in floated payouts, hands Otsuka a medicine it sees as a possibly “paradigm-shifting therapy” in psychiatry.
From biopharmadive.com 1
93




